January 2018
UHN Research The Krembil is the official newsletter of the Krembil Research Institute (formerly the Toronto Western Research Institute). It informs the Toronto Western Hospital community, external stakeholders and interested community members about the exciting news and innovative research happening at the Krembil Research Institute.

Stories in this month's issue:

Donald Weaver, PhD, MD, FRCPC, FCAHS
Director, Krembil Research Institute
University Health Network
 

Krembil in Focus

Year in review letter from Krembil Director Dr. Donald Weaver: "As we enter 2018, I wish to take this opportunity to express my gratitude to the staff, faculty and trainees here at the Krembil. Last year we achieved many successes—from expanding our focus on computational science and enhancing research equipment to gaining new leadership. [Read More]

Powering towards a Parkinson’s Cure

Dr. Lorraine Kalia is one of a group of researchers using IBM Watson to find off-label drugs to treat Parkinson disease. It all began when IBM executive Jonathan Rezek was diagnosed with the disease and was faced with the uncomfortable reality that there is currently no cure. As an executive at IBM, he knew he might be able to help change that. [Read More]

Pinpointing Cause of Stroke

Mutation of KRAS gene, best known for its role in cancer, increases risk of hemorrhagic stroke. [Learn More]
Cures from the Past

Learn how a serendipitous discovery made during World War II is impacting lupus patients today. [Learn More]
A Big Deal for Alzheimer’s

New therapy one step closer to reality as Krembil team partners with French company Servier. [Learn More]
Wisdom of the Crowd

Pooling data from 30 resources enables large-scale research on how genes are regulated. [Learn More]
 

Copyright © 2018, University Health Network, all rights reserved.

If you have any feedback about the newsletter, email us at: www@uhnresearch.ca
To access previous issues, visit the The Krembil archives.